Xenobiotic Bi3+ Coordination by Cysteine-Rich Metallothionein-3 Reveals a Cooperatively Formed Thiolate-Sharing Bi2S5 Cluster.

The field of designing artificial metalloproteins has yet to effectively tackle the incorporation of multimetal clusters, which is a key component of natural metalloproteins, such as metallothioneins (MTs) and calmodulin. MT is a physiological, essential, cysteine-rich metalloprotein that binds to a variety of metals but is only known to form metal-thiolate clusters with Cd2+, Zn2+, and Cu+. Bismuth is a xenobiotic metal and a component of metallodrugs used to treat gastric ulcers and cancer, as well as an emerging metal used in industrial practices. Electrospray ionization mass spectrometry, UV-visible spectroscopy, and extended X-ray absorption fine structure spectroscopy were used to probe the Bi3+ binding site structures in apo-MT3 (brain-located MT) at pH 7.4 and 2 and provide the complete set of binding affinities. We discovered the highly cooperative formation of a novel Bi3+ species, Bi2MT3, under physiological conditions, where each Bi3+ ion is coordinated by three cysteinyl thiolates, with one of the thiolates bridging between the two Bi3+ ions. This cluster structure was associated with a strong visible region absorption band, which was disrupted by the addition of Zn2+ and reversibly disrupted by acidification and increased temperature. This is the first reported presence of bridging cysteines for a xenobiotic metal in MT3 and the Bi2MT structure is the first Bi cluster found in a metalloprotein.

[1]  M. Stillman,et al.  Apo-metallothionein-3 cooperatively forms tightly compact structures under physiological conditions , 2023, The Journal of biological chemistry.

[2]  J. Gassensmith,et al.  Comparative cisplatin reactivity towards human Zn7-Metallothionein-2 and MTF-1 zinc fingers: potential implications in anticancer drug resistance. , 2022, Metallomics : integrated biometal science.

[3]  F. Tezcan,et al.  Overcoming universal restrictions on metal selectivity by protein design , 2022, Nature.

[4]  W. DeGrado,et al.  De novo metalloprotein design , 2021, Nature Reviews Chemistry.

[5]  Hanying Dai,et al.  Metallothionein 1: A New Spotlight on Inflammatory Diseases , 2021, Frontiers in Immunology.

[6]  W. Maret,et al.  The Bioinorganic Chemistry of Mammalian Metallothioneins. , 2021, Chemical reviews.

[7]  J. Zuo,et al.  Highly Dynamic Polynuclear Metal Cluster Revealed in a Single Metallothionein Molecule , 2021, Research.

[8]  M. Stillman,et al.  Structurally restricted Bi(III) metallation of apo-βMT1a: metal-induced tangling. , 2021, Metallomics : integrated biometal science.

[9]  E. Sabbioni,et al.  Metallobiochemistry of ultratrace levels of bismuth in the rat II. Interaction of 205+206Bi3+ with tissue, intracellular and molecular components. , 2021, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[10]  M. Stillman,et al.  The pathways and domain specificity of Cu(I) binding to human metallothionein 1A. , 2020, Metallomics : integrated biometal science.

[11]  G. Cheek,et al.  Electrochemical Investigations of L-Cysteine Interactions with Bismuth Ions , 2020, Journal of The Electrochemical Society.

[12]  M. Stillman,et al.  pH dependence of the non-cooperative binding of Bi3+ to human apo-metallothionein 1A: kinetics, speciation, and stoichiometry. , 2020, Metallomics : integrated biometal science.

[13]  Ying-Wu Lin Rational Design of Artificial Metalloproteins and Metalloenzymes with Metal Clusters , 2019, Molecules.

[14]  J. Zuo,et al.  Multistep Protein Unfolding Scenarios from the Rupture of a Complex Metal Cluster Cd3S9 , 2019, Scientific Reports.

[15]  M. Stillman,et al.  Metallothionein: An Aggressive Scavenger—The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4) , 2018, ACS omega.

[16]  M. Lein,et al.  Bismuth(III) Complex of the [S4]•- Radical Anion: Dimer Formation via Pancake Bonds. , 2017, Journal of the American Chemical Society.

[17]  Gabriele Meloni,et al.  Mammalian Metallothionein-3: New Functional and Structural Insights , 2017, International journal of molecular sciences.

[18]  M. Stillman,et al.  Selective cysteine modification of metal‐free human metallothionein 1a and its isolated domain fragments: Solution structural properties revealed via ESI‐MS , 2017, Protein science : a publication of the Protein Society.

[19]  Kelly E. Duncan,et al.  Metalation kinetics of the human α-metallothionein 1a fragment is dependent on the fluxional structure of the apo-protein. , 2015, Chemistry.

[20]  D. Griffith,et al.  Current and Potential Applications of Bismuth-Based Drugs , 2014, Molecules.

[21]  Yizeng Liang,et al.  pH-Dependent Coordination of Pb2+ to Metallothionein2: Structures and Insight into Lead Detoxification , 2014, Inorganic chemistry.

[22]  P. Junk,et al.  Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori. , 2013, Chemistry.

[23]  F. Frézard,et al.  Improved Antileishmanial Activity of Dppz through Complexation with Antimony(III) and Bismuth(III): Investigation of the Role of the Metal , 2012, Molecules.

[24]  D. Griffith,et al.  The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum. , 2012, Dalton transactions.

[25]  V. Adam,et al.  Mammalian metallothioneins: properties and functions. , 2012, Metallomics : integrated biometal science.

[26]  S. Yin,et al.  Synthesis and Structure of Binuclear O/S‐Bridged Organobismuth Complexes and Their Cooperative Catalytic Effect on CO2 Fixation , 2012 .

[27]  Hongzhe Sun,et al.  Recent advances in bioinorganic chemistry of bismuth , 2012, Current Opinion in Chemical Biology.

[28]  Gabriele Meloni,et al.  Chemistry and biology of mammalian metallothioneins , 2011, JBIC Journal of Biological Inorganic Chemistry.

[29]  H. Kozłowski,et al.  Metal binding ability of cysteine-rich peptide domain of ZIP13 Zn2+ ions transporter. , 2011, Inorganic chemistry.

[30]  M. Stillman,et al.  The "magic numbers" of metallothionein. , 2011, Metallomics : integrated biometal science.

[31]  F. Mégraud,et al.  Metalloantibiotics: Synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori , 2009, Acta pharmaceutica.

[32]  I. Císařová,et al.  Synthesis, Structure, and Reactivity of Intramolecularly Coordinated Organoantimony and Organobismuth Sulfides , 2009 .

[33]  M. Stillman,et al.  Kinetic analysis of arsenic-metalation of human metallothionein: significance of the two-domain structure. , 2008, Journal of the American Chemical Society.

[34]  J. Teissié,et al.  Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity. , 2008, Nature chemical biology.

[35]  Li Xu,et al.  pH-dependent displacement of [Bi(citrate)](-) with cysteine: Synthesis, spectroscopic and X-ray crystallographic characterization of Bi(cysteine)3. , 2008, Journal of inorganic biochemistry.

[36]  E. Lork,et al.  Hypervalent organobismuth(iii) carbonate, chalcogenides and halides with the pendant arm ligands 2-(Me2NCH2)C6H4 and 2,6-(Me2NCH2)2C6H3. , 2008, Dalton transactions.

[37]  M. Stillman,et al.  Arsenic binding to human metallothionein. , 2006, Journal of the American Chemical Society.

[38]  M. Vašák Advances in metallothionein structure and functions. , 2005, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[39]  W. Li,et al.  Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)). , 2003, Journal of the American Chemical Society.

[40]  G. Balázs,et al.  Synthesis and characterization of R2SbH, R2BiH, and R2Bi-BiR2 [R = (Me3Si)2CH] , 2002 .

[41]  P. Coyle,et al.  Metallothionein: the multipurpose protein , 2002, Cellular and Molecular Life Sciences CMLS.

[42]  P. Sadler,et al.  Interactions of Bismuth Complexes with Metallothionein(II)* , 1999, The Journal of Biological Chemistry.

[43]  R. Palmiter The elusive function of metallothioneins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Sadler,et al.  THE BIOLOGICAL AND MEDICINAL CHEMISTRY OF BISMUTH , 1997 .

[45]  L. Tillman,et al.  safety of bismuth in the treatment of gastrointestinal diseases , 1996, Alimentary pharmacology & therapeutics.

[46]  P. Sadler,et al.  Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly) , 1996 .

[47]  A. Agócs,et al.  SPECTROSCOPIC, STRUCTURAL, AND MASS SPECTROMETRIC STUDIES ON TWO SYSTEMATIC SERIES OF DITHIABISMUTH(III) HETEROCYCLES : IDENTIFICATION OF BISMUTHENIUM CATIONS AND THEIR SOLVENT COMPLEXES , 1996 .

[48]  R. Palmiter,et al.  Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.

[49]  K. Titani,et al.  The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.

[50]  B. Vallee,et al.  Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.

[51]  J. Otvos,et al.  Structure of the metal clusters in rabbit liver metallothionein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Hill,et al.  Investigation of the structure of metallothioneins by proton nuclear magnetic resonance spectroscopy. , 1980, Biochemistry.

[53]  S. Kirschner,et al.  Anticancer and potential antiviral activity of complex inorganic compounds. , 1966, Journal of medicinal chemistry.

[54]  B. Vallee,et al.  A CADMIUM PROTEIN FROM EQUINE KIDNEY CORTEX , 1957 .

[55]  Jie Liu,et al.  Metallothionein: an intracellular protein to protect against cadmium toxicity. , 1999, Annual review of pharmacology and toxicology.

[56]  C. Tohyama,et al.  Protective role of metallothionein in renal toxicity of cisplatinum , 1997, Cancer Chemotherapy and Pharmacology.

[57]  Fiona J. Lawlor,et al.  Co-ordination complexes of the bismuth(III) thiolate Bi(SC6F5)3 , 1995 .

[58]  K. Ebert,et al.  Tetramesityldibismutan, Bis(dimesitylbismut)- und Bis(dimethylbismut)chalkogenide / Tetramesityldibismuthane, Bis(dimesitylbismuth)- and Bis(dimethylbismuth)chalcogenides , 1995 .